Hamill Laura — SEC Form 4 filings
SEC reporting owner CIK 1751804. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-13 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) | Director | 3 | — | — | 12 |
| Jazz Pharmaceuticals plc (JAZZ) | Director | 4 | — | — | 6 |
| FATE THERAPEUTICS INC (FATE) | Director | 1 | — | — | 1 |
Form 4 filings — Hamill Laura
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 14 @ $244.06 · Tax withholding (F): 1,692 @ $241.39 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-06-15 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 175,800 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Code (U): 5,825 @ $8.60 · Disposition to issuer (D): 25,080 · Disposition to issuer (D): 27,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 13,950 (derivative) · +2 more | EDGAR |
| 2025-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,507 @ $0 · Tax withholding (F): 1,805 @ $111.25 | EDGAR |
| 2025-07-02 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 25,080 @ $0 · Grant/award (A): 33,450 (derivative) @ $0 | EDGAR |
| 2024-08-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,731 @ $0 | EDGAR |
| 2024-06-13 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 3,495 @ $0 · Grant/award (A): 14,545 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1751804 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →